[Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
Halawa
B
B
Mazurek
W
W
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000359:Aftercare; D000368:Aged; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D008790:Metoprolol / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality*; D010096:Oxprenolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D013997:Time Factors; D013999:Timolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D010096:Oxprenolol; D013999:Timolol; D011433:Propranolol; D008790:Metoprolol
Wpływ leków beta-adrenolitycznych na czas przezycia chorych z przebytym zawałem serca.